Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 15 studies | 39% ± 16% | |
basal cell | 13 studies | 36% ± 18% | |
epithelial cell | 13 studies | 50% ± 23% | |
secretory cell | 10 studies | 65% ± 14% | |
respiratory goblet cell | 7 studies | 78% ± 26% | |
club cell | 6 studies | 73% ± 20% | |
transit amplifying cell | 5 studies | 29% ± 11% | |
platelet | 5 studies | 26% ± 6% | |
mucus secreting cell | 5 studies | 38% ± 30% | |
deuterosomal cell | 4 studies | 62% ± 14% | |
duct epithelial cell | 4 studies | 96% ± 2% | |
squamous epithelial cell | 4 studies | 79% ± 17% | |
enterocyte | 4 studies | 23% ± 5% | |
goblet cell | 4 studies | 41% ± 32% | |
ionocyte | 3 studies | 25% ± 6% | |
serous secreting cell | 3 studies | 44% ± 14% | |
pancreatic ductal cell | 3 studies | 52% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 5 studies | 47% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 55% | 1638.90 | 179 / 328 | 87% | 1677.63 | 155 / 178 |
stomach | 53% | 7964.47 | 191 / 359 | 81% | 2164.07 | 233 / 286 |
lung | 81% | 2783.74 | 470 / 578 | 53% | 458.38 | 613 / 1155 |
intestine | 36% | 3022.18 | 351 / 966 | 88% | 1775.96 | 465 / 527 |
esophagus | 41% | 8137.54 | 597 / 1445 | 73% | 1841.10 | 134 / 183 |
prostate | 67% | 2760.33 | 164 / 245 | 24% | 93.86 | 118 / 502 |
peripheral blood | 80% | 18041.20 | 745 / 929 | 0% | 0 | 0 / 0 |
bladder | 29% | 679.57 | 6 / 21 | 50% | 600.94 | 253 / 504 |
ovary | 1% | 10.88 | 2 / 180 | 76% | 646.87 | 327 / 430 |
liver | 41% | 1331.33 | 92 / 226 | 35% | 347.14 | 141 / 406 |
spleen | 74% | 2707.74 | 179 / 241 | 0% | 0 | 0 / 0 |
uterus | 9% | 466.54 | 15 / 170 | 58% | 817.05 | 266 / 459 |
kidney | 48% | 923.87 | 43 / 89 | 18% | 120.79 | 166 / 901 |
tonsil | 0% | 0 | 0 / 0 | 60% | 727.63 | 27 / 45 |
breast | 39% | 816.90 | 181 / 459 | 9% | 38.51 | 102 / 1118 |
thymus | 11% | 246.15 | 70 / 653 | 23% | 71.12 | 139 / 605 |
skin | 30% | 495.52 | 549 / 1809 | 3% | 22.19 | 14 / 472 |
adrenal gland | 7% | 80.10 | 17 / 258 | 1% | 1.54 | 2 / 230 |
adipose | 3% | 24.82 | 32 / 1204 | 0% | 0 | 0 / 0 |
heart | 2% | 17.20 | 20 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 1% | 5.27 | 9 / 1335 | 0% | 0 | 0 / 0 |
muscle | 0% | 5.81 | 2 / 803 | 0% | 0 | 0 / 0 |
brain | 0% | 0.60 | 3 / 2642 | 0% | 0 | 0 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006915 | Biological process | apoptotic process |
GO_0015891 | Biological process | siderophore transport |
GO_0120162 | Biological process | positive regulation of cold-induced thermogenesis |
GO_0042742 | Biological process | defense response to bacterium |
GO_0045087 | Biological process | innate immune response |
GO_0005615 | Cellular component | extracellular space |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005576 | Cellular component | extracellular region |
GO_0035580 | Cellular component | specific granule lumen |
GO_1903981 | Molecular function | enterobactin binding |
GO_0140315 | Molecular function | iron ion sequestering activity |
GO_0005506 | Molecular function | iron ion binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | LCN2 |
Protein name | Neutrophil gelatinase-associated lipocalin (NGAL) (25 kDa alpha-2-microglobulin-related subunit of MMP-9) (Lipocalin-2) (Oncogene 24p3) (Siderocalin) (p25) Lipocalin 2 |
Synonyms | HNL NGAL |
Description | FUNCTION: Iron-trafficking protein involved in multiple processes such as apoptosis, innate immunity and renal development . Binds iron through association with 2,3-dihydroxybenzoic acid (2,3-DHBA), a siderophore that shares structural similarities with bacterial enterobactin, and delivers or removes iron from the cell, depending on the context. Iron-bound form (holo-24p3) is internalized following binding to the SLC22A17 (24p3R) receptor, leading to release of iron and subsequent increase of intracellular iron concentration. In contrast, association of the iron-free form (apo-24p3) with the SLC22A17 (24p3R) receptor is followed by association with an intracellular siderophore, iron chelation and iron transfer to the extracellular medium, thereby reducing intracellular iron concentration. Involved in apoptosis due to interleukin-3 (IL3) deprivation: iron-loaded form increases intracellular iron concentration without promoting apoptosis, while iron-free form decreases intracellular iron levels, inducing expression of the proapoptotic protein BCL2L11/BIM, resulting in apoptosis (By similarity). Involved in innate immunity; limits bacterial proliferation by sequestering iron bound to microbial siderophores, such as enterobactin . Can also bind siderophores from M.tuberculosis . . |
Accessions | X6R8F3 ENST00000277480.7 [P80188-1] P80188 ENST00000373017.5 [P80188-1] ENST00000372998.1 |